The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006
Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer?: Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers Source: Eur Respir J 2001; 18: 942-950 Year: 2001
Flow cytometry vs. immunohistochemistry in determining CD4+/CD8+ cell ratio in BAL fluid from patients with interstitial lung diseases Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
T cell analyses in blood, BAL and induced sputum from lung transplant recipients Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Expression of apoptotic markers in lung tissue of COPD patients: preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 748s Year: 2006
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Blood levels of TNF-α, IFN-γ, IL-10, TGF-β1 and lung functional parameters in patients with advanced and earlier lung sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function Source: Eur Respir J 2006; 28: Suppl. 50, 278s Year: 2006
Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003
Perforin expression in lung tissue of COPD patients: preliminary results Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
p16(ink4) expression and spirometry tests have similar survival outcomes values in non-small-cell lung cancer patients Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Comparison of induced and spontaneous sputum in the diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001
Lung function, clinical status and serum/sputum IL-10 levels in CF patients Source: Eur Respir J 2006; 28: Suppl. 50, 484s Year: 2006
The trend of pulmonary function tests over time in COPD patients with different levels of blood eosinophils Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006
Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021
Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
A follow-up study with broncho-alveolar lavage (BAL) to assess the importance of airway colonization in lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006
Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020